Literature DB >> 34022128

Structures and target RNA preferences of the RNA-binding protein family of IGF2BPs: An overview.

Sophie Marianne Korn1, Corinna Jessica Ulshöfer2, Tim Schneider2, Andreas Schlundt3.   

Abstract

Insulin-like growth factor 2 mRNA-binding proteins (IMPs, IGF2BPs) act in mRNA transport and translational control but are oncofetal tumor marker proteins. The IMP protein family represents a number of bona fide multi-domain RNA-binding proteins with up to six RNA-binding domains, resulting in a high complexity of possible modes of interactions with target mRNAs. Their exact mechanism in stability control of oncogenic mRNAs is only partially understood. Our and other laboratories' recent work has significantly pushed the understanding of IMP protein specificities both toward RNA engagement and between each other from NMR and crystal structures serving the basis for systematic biochemical and functional investigations. We here summarize the known structural and biochemical information about IMP RNA-binding domains and their RNA preferences. The article also touches on the respective roles of RNA secondary and protein tertiary structures for specific RNA-protein complexes, including the limited knowledge about IMPs' protein-protein interactions, which are often RNA mediated.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IGF2BPs (IMPs); KH domain; NMR spectroscopy; RNA-binding domain; RRM domain; X-ray crystallography; mRNA; mRNP; miRNA; multi-domain RNA-binding proteins

Mesh:

Substances:

Year:  2021        PMID: 34022128     DOI: 10.1016/j.str.2021.05.001

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  5 in total

Review 1.  KH domain proteins: Another family of bacterial RNA matchmakers?

Authors:  Mikolaj Olejniczak; Xiaofang Jiang; Maciej M Basczok; Gisela Storz
Journal:  Mol Microbiol       Date:  2021-11-19       Impact factor: 3.979

2.  Integrated analyses of an RNA binding protein-based signature related to tumor immune microenvironment and candidate drugs in osteosarcoma.

Authors:  Abdulraheem Gul Mohammad; Dapeng Li; Rong He; Xuan Lei; Lianghao Mao; Bing Zhang; Xinyu Zhong; Zhengyu Yin; Wenbing Cao; Wenchao Zhang; Ruoxuan Hei; Qiping Zheng; Yiming Zhang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

Review 3.  Advances in the study of RNA-binding proteins in diabetic complications.

Authors:  Xinyue Chen; Jiaqiang Wu; Zhangwang Li; Jiashu Han; Panpan Xia; Yunfeng Shen; Jianyong Ma; Xiao Liu; Jing Zhang; Peng Yu
Journal:  Mol Metab       Date:  2022-05-18       Impact factor: 8.568

Review 4.  The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer.

Authors:  Chao-Yue Sun; Di Cao; Bin-Bin Du; Cun-Wu Chen; Dong Liu
Journal:  Int J Biol Sci       Date:  2022-03-28       Impact factor: 10.750

5.  Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.

Authors:  Danxia Chen; Wenhao Guo; Hailan Yu; Jianhua Yang
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.